Public COA audit

Semaglutide · Semaglutide 10mg

Audited September 5, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
72
Confidence
85%
Panels
3/7
Purity (printed)
99.94%

Scored moderately because the document is mostly consistent but carries soft concerns, limited panel coverage (3/7), 2 soft concerns, and notable note: "High purity confirmed". To improve: include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
GS10-042026-1
Identity method
LC-MS
Sample date
2026-04-20
Issue date
2026-04-22

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

3 of 7 present · 3 passed · 0 failed · 0 reported · 4 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    GLP SM Confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.94%

  • Heavy metals

    Not on this certificate file

    Lead, arsenic, cadmium, mercury, or similar limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Tested · passed · core

    LAL or chromogenic endotoxin assay.

    Pass (both replicates), Assay Sensitivity: ≤0.05 EU/mL

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.94% purity by HPLC-UV with clean chromatogram showing single major peak. This is normal for research-grade peptides.

  • Identity confirmed by LC-MS

    Mass spectrometry confirmation provided with spectrum showing expected GLP-1 peptide mass peaks.

  • Endotoxin testing performed

    Two replicates of LAL assay per USP <85>, both passed with sensitivity ≤0.05 EU/mL.

  • Batch information present

    Lot number GS10-042026-1, net content 9.75 mg (97.5% of labeled 10mg), accession number 2604200583.

  • Dates within normal range

    Received 2026-04-20, reported 2026-04-22 (2-day turnaround). Both dates are before today (2026-09-05).

  • Lab verification uncertain

    Freedom Diagnostics Testing website and contact provided, but independent verification of lab accreditation/credentials not possible from document alone. No ISO/GMP certification visible.

  • Limited testing scope

    Heavy metals, microbial contamination, sterility, and residual solvents/water content not tested. This is common for basic peptide COAs but limits comprehensive quality assessment.

  • Professional presentation

    Document includes logo, signature, chromatogram, mass spectrum, appropriate disclaimers for research use only.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.